Heme Today Videos

Patrick DalySickle Cell Disease | April 23, 2024
Dr. Vadivelan shared her study on pituitary and pancreatic iron deposition in patients with SCD at the 2024 ASPHO Conference.
View More
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 12, 2024
Dr. Ansong-Ansongton shared what National Minority Health Month and Celebrate Diversity Month mean to him at ASPHO 2024.
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 9, 2024
Dr. Ansong-Ansongton described data on the impact of abnormal mitochondrial retention and cold in red blood cells in SCD.
Erica Mamauag, MDHemophilia | April 9, 2024
Dr. Mamauag details her study on the need for factor VIII infusions in patients with tolerized hemophilia A on emicizumab.
Anjali Sharathkumar, MDAnemia | April 5, 2024
Dr. Sharathkumar shared data from her 2024 ASPHO presentation on romiplostim in children with severe aplastic anemia and MDS.
Zaina Inam, MDSickle Cell Disease | April 5, 2024
The study evaluated transplant outcomes in pediatric patients with SCD who had a history of red blood cell alloimmunization.
Patrick DalyPNH | March 14, 2024
Dr. Griffin shares data from their real-world study on pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.
Patrick DalyPolycythemia Vera | March 1, 2024
Dr. Grunwald of the Atrium Health Levine Cancer Institute, discusses caring for patients with PV on rare disease day.
Zahra Pakbaz, MDSickle Cell Disease | February 27, 2024
Dr. Pakbaz describes some of the difficulties faced by patients with SCD as they switch from pediatric to adult programs.
Patrick DalySickle Cell Disease | February 13, 2024
Drs. Grant, Sutin, and Lin discuss their pilot study investigating cerebral hemodynamics in infants with sickle cell disease.
John Strouse, MD, PhDSickle Cell Disease | March 19, 2024
Dr. Pakbaz and Dr. Strouse discuss their experiences practicing classical hematology and where the speciality is heading.
Patrick DalySickle Cell Disease | February 8, 2024
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Patrick DalySickle Cell Disease | February 8, 2024
Dr. Pakbaz describes the significant need for specialists dedicated to adult patients with noncancer blood disorders.
Patrick DalyMyelofibrosis | February 16, 2024
Dr. Hobbs shared findings supporting the safety and feasibility of continuing ruxolitinib during and after HSCT for MF.
Hana Safah, MDMDS | February 8, 2024
The panel shares their outlook for the future of MDS research and treatment.
Hana Safah, MDMDS | February 8, 2024
Dr. Tanaka outlines a biomarker study that observed reduced inflammation in patients with MDS treated with luspatercept.
Hana Safah, MDMDS | February 8, 2024
The panel discussed a study that assessed quality of life and PROs in patients receiving luspatercept for MDS.
Hana Safah, MDMDS | February 8, 2024
The panel discusses whether starting treatment with luspatercept sooner in patients with MDS is beneficial.
Hana Safah, MDMDS | February 8, 2024
Dr. Shammo shares her reaction to a study that assessed mutational burden and impact on primary outcomes in COMMANDS.
Hana Safah, MDMDS | February 8, 2024
Dr. Safah outlines the findings from the full analysis of the COMMANDS trial.
Advertisement
Advertisement
Latest News

May 27, 2024